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Feasibility and Safety of Extensive Upper Abdominal Surgery  
in Elderly Patients with Advanced Epithelial Ovarian Cancer 
We performed a retrospective study to evaluate the feasibility and safety of extensive 
upper abdominal surgery (EUAS) in elderly (≥65 yr) patients with advanced ovarian cancer. 
Records of patients with advanced epithelial ovarian cancer who received surgery at our 
institution between January 2001 and June 2005 were reviewed. A total of 137 patients 
including 32 (20.9%) elderly patients were identified. Co-morbidities were present in 37.5% 
of the elderly patients. Optimal cytoreduction was feasible in 87.5% of the elderly while 
95.2% of young patients were optimally debulked (P=0.237). Among 77 patients who 
received one or more EUAS procedures, 16 (20.8%) were elderly. Within the cohort, the 
complication profile was not significantly different between the young and the elderly, 
except for pleural effusion and pneumothorax (P=0.028). Elderly patients who received 2 
or more EUAS procedures, when compared to those 1 or less EUAS procedure, had 
significantly longer operation times (P=0.009), greater blood loss (P=0.002) and more 
intraoperative transfusions (P=0.030). EUAS procedures are feasible in elderly patients with 
good general condition. However, cautious peri-operative care should be given to this 
group because of their vulnerability to pulmonary complications and multiple EUAS 
procedures.
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INTRODUCTION
Ovarian cancer is the leading cause of death among female re-
productive tract cancers. Data from the Surveillance, Epidemi-
ology, and End Results (SEER) program database (1988-2001) 
shows that 45.6% of ovarian cancer are diagnosed among wom-
en older than 65 yr of age, and 76.9% of these elderly patients 
are diagnosed at an advanced stage of disease (1). Even within 
the same stages, young women survive longer than older wom-
en even after adjusting for life expectancy (2, 3). Several reports 
have suggested that the lower survival rate of elderly patients 
with ovarian cancer may be largely attributed to less aggressive 
treatment (4-9).
  Maximal cytoreductive surgery is the most important proce-
dure in the management of advanced ovarian cancer. However, 
it has been noted that elderly patients receive fewer operations 
and a lower percentage of optimal debulking (4, 10). Despite 
the common belief that elderly patients might not be able to 
tolerate the debilitating effects of radical surgery, recent devel-
opments in the field of peri-operative care, anesthesiology, and 
surgical techniques have significantly improved general safety 
and operability of radical surgery. Fortunately, a number of re-
cent studies have reported that standard cytoreductive surgery 
is feasible and safe in elderly patients with advanced ovarian 
cancer (10-14). In these reports, optimal cytoreduction rates in 
elderly patients varied between 45% and 80% (10, 12-14). 
  Several studies have indicated that the application of more 
comprehensive surgical methods targeting upper abdominal 
disease can improve optimal cytoreduction rates and overall 
survival (15-21). The surgical approach incorporates the utiliza-
tion of extensive upper abdominal surgery (EUAS), such as dia-
phragm stripping and/or resection, splenectomy, distal pan-
createctomy, partial liver resection, resection of tumor from the 
porta hepatis, and cholecystectomy. However, in elderly pa-
tients, incorporation of EUAS into standard surgery raises a con-
cern that elderly patients may not tolerate these radical and ex-
tensive procedures. Although few studies have addressed the 
feasibility of these procedures in elderly patients (12), there is 
scant data regarding the feasibility of EUAS in elderly patients 
with advanced ovarian cancer. The aim of this study was to re-
view the experience of EUAS in elderly ovarian cancer patients 
and assess the feasibility and safety of these procedures.
MATERIALS AND METHODS
With the approval of our Institutional Review Board (NCCNCS- Lim MC, et al.  •  Extensive Surgery In Elderly with Ovarian Cancer
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09-303), we retrospectively identified patients who had under-
gone exploratory laparotomy for advanced epithelial ovarian 
cancer between January 2001 and June 2005 at the National 
Cancer Center of Korea. The following variables were recorded: 
age at diagnosis, histologic type, tumor grade, stage of the tu-
mor, medical co-morbidities for Charlson index (22), preopera-
tive CA125 value, presence of ascites, surgical procedures per-
formed, size of residual disease, estimated blood loss, intraop-
erative complications, length of hospitalization, postoperative 
morbidity within 30 days of surgery, and survival outcome. Re-
cords from a center-based tumor registry were used to verify 
survival of the patients. Survival was calculated from the date of 
diagnosis until the last follow-up visit or death. Elderly patients 
were defined as women 65 yr of age or older.
  All operations were performed by gynecologic oncologist-
leading comprehensive surgery team including colorectal sur-
geons, urologic surgeons, thoracic surgeons and hepatobiliary 
surgeons (23). Standard cytoreductive procedures included hys-
terectomy, oophorectomy, low anterior resection, lymphade-
nectomy, and omentectomy. EUAS is defined as splenectomy, 
distal pancreatectomy, cholecystectomy, liver resection, dia-
phragm stripping and/or resection, and partial gastrectomy. 
Records of residual mass were retrieved for all patients and op-
timal cytoreduction was defined as a residual tumor size <1 cm 
in size. All patients were staged according to the International 
Federation of Gynecology and Obstetrics (FIGO) staging sys-
tem. All specimens were reviewed by gynecologic pathologists 
and graded according to the World Health Organization classi-
fication. Prophylaxis for thrombotic complications was given to 
all the patients who underwent surgery.
  Data analyses were performed using STATA software (College 
Station, TX, USA). The median values between the two groups 
were compared using the Mann-Whitney U test. Frequency data 
were evaluated by the Fischer exact test or chi-square test, as 
appropriate. Survival rates were calculated using Kaplan-Meier 
methods, and differences were evaluated by the log-rank test 
and Cox hazard ratio analysis. All P values presented are two-
sided, and associations are considered significant if the P value 
<0.05.
 
RESULTS
A total of 137 patients with advanced ovarian cancer including 
32 elderly patients (≥65 yr of age) underwent primary cytoreduc-
tive surgery. The characteristics of the patients are described in 
Table 1. The median age of the elderly patients was 67 yr (range, 
65-79 yr). Co-morbidities were present in 37.5% of the elderly 
patients. The number of co-morbidities was higher in the elder-
ly without statistical significance (0.3 vs. 0.5, P=0.078). Charlson 
index (22) was higher in the elderly patients (0.188 vs. 0.167, P= 
0.049). The most common co-morbidity was cardiovascular dis-
ease. Four of 32 (12.5%) elderly patients had multiple co-mor-
bidities. At the time of hospitalization, tumor stage, grade, and 
histology were not different between the two groups. Although 
the initial level of serum CA-125 was not different between the 
two groups, ascites was more frequently found in the elderly 
Table 1. Clinical characteristics of 137 advanced ovarian cancer patients
Young (<65 yr) Elderly (>=65 yr) Total P value
Number of patients 105 32 137
Age, median (range) (yr)   53 (26-64)   67 (65-79)   57 (26-79)
Co-morbidity 
   Cardiovascular 
   Endocrine 
   Thromboembolic 
   Pulmonary 
   Neurologic 
   Hepatic 
   Nephrotic 
   17 (16.2%)
   4 (3.8%)
0 (0%)
   7 (6.7%)
0 (0%)
     1 (0.95%)
     1 (0.95%)
   10 (31.3%)
     6 (18.8%)
0 (0%)
0 (0%)
0 (0%)
0 (0%)
0 (0%)
 
  27 (19.7%)
 10 (7.3%)
0 (0%)
   7 (5.1%)
0 (0%)
0 (0%)
0 (0%)
Number of co-morbidity  0.314 0.531 0.365 0.078
Multiple co-morbidity     7 (6.6%)      4 (12.5%)  11 (8.0%)
Charlson Index  0.067 0.188 0.095  0.049*  
Stage of disease
   III 
   IV 
   89 (84.8%)
   16 (15.2%)
   24 (75.0%)
     8 (25.0%)
 113 (82.5%)
   24 (17.5%)
0.203
Tumor grade
†
   1–2
   3 
   48 (51.6%)
   45 (48.3%)
   11 (37.9%)
   18 (62.1%)
   59 (48.4%)
   63 (51.6%)
0.198
Histology 
   Serous 
   Non-serous 
   92 (87.6%)
   13 (12.4%)
   30 (93.8%)
   2 (6.2%)
 122 (89.1%)
   15 (10.9%)
 0.331
‡
Preoperative CA125 median (range) 1,421 (5.5–22,800) 1,212 (9.8–20,900) 1,296 (5.5-22,800)  0.382*
Large-volume ascites    65 (61.9%)    25 (78.1%)    90 (65.7%) 0.091
*Mann-Whitney test was used; 
†In 15 patients, tumor grade was not determined; 
‡Fisher’s exact test was used.Lim MC, et al.  •  Extensive Surgery In Elderly with Ovarian Cancer
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cohort without statistical significance (61.9% vs. 78.1%, P=0.091).
  Standard surgery for ovarian cancer was performed on all 
patients enrolled in the present study. EUAS procedures were 
applied to all patients whenever it was necessary to debulk the 
tumor optimally. The list of EUAS procedures and the operative 
outcomes for each cohort are listed in Table 2. The most com-
monly performed EUAS procedure was splenectomy (43.8%). 
The second most common procedure was diaphragm stripping 
and/or resection (23.4%). Overall, 77 patients, including 16 el-
derly patients, received EUAS. The proportion of patients who 
received EUAS was not different between the two groups (58.1% 
vs. 50.0%, P=0.420). The proportion of patients who received 
multiple EUAS procedures was similar between the two groups 
(19.1% vs. 25.0%, P=0.465). The median estimated blood loss 
for the entire groups was 850 mL. The estimated blood loss and 
intraoperative transfusion rate were statistically similar between 
the two groups. The optimal debulking rate (residual mass <1 
cm) was 95.2% for young patients and 87.5% for elderly patients 
(P=0.213).
  Intraoperative injuries and post-operative morbidities within 
30 days were described in Table 3. The most common intraop-
erative injury associated with EUAS was diaphragm perforation, 
resulting from aggressive diaphragmatic tumor debulking or di-
aphragmatic full thickness resection. The most common medi-
cal morbidity was infection. Pleural effusion and pneumotho-
rax were the most common morbidities which possibly resulted 
from EUAS. We also observed that these complications are more 
frequent in elderly patients, but without statistical significance 
(6.7% vs. 18.8%, P=0.077). A total of 77 of 153 women received 
one or more EUAS procedures during their surgery. Among 
these patients, complications and morbidities were compared 
according to age (Table 4). Overall, the complications and mor-
Table 2. Surgical procedures and operative outcome in 137 advanced ovarian cancer patients
Young (n=105) Elderly (n=32) Total (n=137) P value
Upper abdominal procedures    61 (58.1%) 16 (50.0%)   77 (56.2%) 0.420
   Splenectomy 
   Other upper abdominal procedures*
   48 (45.7%)
   32 (30.5%)
12 (37.5%)
13 (40.6%)
  60 (43.8%)
  45 (32.9%)
0.412
0.285
Multiple upper abdominal procedures (more than 1)     20 (19.1%)   8 (25.0%)   28 (20.4%) 0.465
Estimated blood loss (EBL) median (range) 800 (150-15,000)   1,000 (300-2,300) 850 (150-15,000)  0.237
†
Intraoperative Transfusion     62 (59.1%) 21 (65.6%)   83 (60.6%) 0.505
Hospital stay (days) 18.5 (9-137) 18.5 (9-62)   18 (9-137)  0.431
†
Optimal resection (residual mass <1 cm)  100 (95.2%) 23 (87.5%) 128 (93.4%)  0.213
‡
*Including cholecystectomy, diaphragm resection/stripping, distal pancreatectomy, liver resection, and partial gastrectomy; 
†Mann-Whitney test was used; 
‡Fisher’s exact test 
was used.
Table 3. Intraoperative and postoperative complications in 137 advanced ovarian 
cancer patients
Young
(n=105)
Elderly
(n=32)
Total
(n=137)
P 
value
Intraoperative surgical injuries 8 (7.6%) 4 (12.5%) 12 (8.8%) 0.474
   Urologic injury 
   Vascular injury 
   Gastrointestinal injury 
   Diaphragm injury 
2 (1.9%)
1 (1.0%)
0 (0%)
5 (4.8%)
1 (3.1%)
1 (3.1%)
1 (3.1%)
3 (9.4%)
3 (2.2%)
2 (1.5%)
1 (0.7%)
8 (5.8%)
Postoperative morbidities 
  (30 days)
24 (22.9%) 10 (31.3%) 34 (24.8%) 0.355
   Thromboembolic 
   Renal 
   Respiratory 
   Infectious 
   Would complication 
   Metabolic 
   Ileus 
   Psychiatric 
1 (1.0%)
0 (0%)
1 (1.0%)
8 (7.6%)
3 (2.9%)
1 (1.0%)
4 (3.8%)
1 (1.0%)
0 (0%)
1 (3.1%)
2 (6.3%)
2 (6.3%)
0 (0%)
1 (3.1%)
0 (0%)
0 (0%)
1 (0.7%)
1 (0.7%)
3 (2.2%)
10 (7.3%)
3 (2.2%)
2 (1.5%)
4 (2.9%)
1 (0.7%)
Iatrogenic surgical morbidities 12 (11.4%) 6 (18.8%) 18 (13.1%) 0.368
   Pleural effusion/
      pneumothorax*
   Pancreatic leakage/
       pseudocyst 
   Lymphocele/lymphedema 
   Fistula of urogenital/
        gastrointestinal tract 
7 (6.7%)
2 (1.9%)
3 (2.9%)
1 (1.0%)
6 (18.8%)
1 (3.1%)
1 (3.1%)
0 (0%)
13 (9.5%)
3 (2.2%)
4 (2.9%)
1 (0.7%)
*Fisher exact test, P value=0.077.
Table 4. Comparison of complications between young and elderly patients who received 
upper abdominal surgical procedures 
Young
(n=61)
Elderly
(n=16)
Total
(n=77)
P 
value
Intraoperative surgical injuries 7 (11.5%) 1 (6.3%) 8 (10.4%) 0.683
   Urologic injury 
   Vascular injury 
   Gastrointestinal injury 
   Diaphragm injury 
1 (1.6%)
1 (1.6%)
0 (0%)
5 (8.2%)
0 (0%)
1 (6.3%)
0 (0%)
0 (0%)
1 (1.3%)
2 (2.6%) 
0 (0%)
5 (6.5%)
30 days postoperative 
  morbidities 
16 (26.2%) 2 (12.5%) 18 (23.4%) 0.332
   Thromboembolic 
   Renal 
   Respiratory 
   Infectious 
   Would complication 
   Metabolic 
   Ileus 
   Psychiatric 
0 (0%)
0 (0%)
1 (1.6%)
7 (11.5%)
3 (4.9%)
1 (1.6%)
4 (6.6%)
1 (1.6%)
0 (0%)
0 (0%)
0 (0%)
1 (6.3%)
0 (0%)
1 (6.3%)
0 (0%)
0 (0%)
0 (0%)
0 (0%)
1 (1.3%)
8 (10.4%)
3 (3.9%)
2 (2.6%)
4 (5.2%)
1 (1.3%)
Iatrogenic surgical morbidities 9 (14.8%) 5 (31.3%) 14 (18.2%) 0.152
   Pleural effusion/
      pneumothorax*
   Pancreatic leakage/
      pseudocyst 
   Lymphocele/lymphedema 
   Fistula of urogenital/
      gastrointestinal tract 
5 (8.2%)
2 (3.3%)
3 (4.9%)
0 (0%)
5 (31.3%)
1 (6.3%)
1 (6.3%)
0 (0%)
10 (11.0%)
3 (3.9%)
4 (5.2%)
0 (0%)
*P=0.028, by Fisher’s exact test.Lim MC, et al.  •  Extensive Surgery In Elderly with Ovarian Cancer
DOI: 10.3346/jkms.2010.25.7.1034 http://jkms.org   1037
bidities were not significantly different. However, pleural effu-
sion and pneumothorax were significantly more common in 
the elderly group (8.2% vs. 31.3%, P=0.028). Among the 5 elderly 
patients who received upper abdominal procedures and expe-
rienced postoperative pleural effusions or pneumothorax, five 
patients had resection and/or stripping of the diaphragm and 
three patients had splenectomy. None of the patients had ma-
lignant effusions before surgery. Among the five patients, one 
patient developed a pneumothorax during resection of the dia-
phragm; the patient recovered well with conservative care, in-
cluding tube drainage. Four patients had postoperative pleural 
effusions which were successfully managed with tube drainage. 
In one of the four patients, pneumonia was developed. Despite 
intensive care, she died of infection after 51 postoperative days.
  In 32 elderly patients with advanced ovarian cancer, we com-
pared operative outcomes and complications according to the 
multiplicity of EUAS procedures (Table 5). The age, stage of the 
disease, number of co-morbidities, Charlson index, and initial 
CA-125 were similar between both groups. However, we ob-
served that the elderly patients who received multiple (2 or more) 
upper abdominal surgical procedures had increased blood loss 
(800 vs. 1,600 mL, P=0.002), more frequent intraoperative trans-
fusions (54.2% vs. 100%, P=0.030), and longer operating times 
(422.5 min vs. 609.5 min, P=0.002). Also, the elderly patients with 
multiple upper abdominal procedures had more frequent iat-
rogenic surgical morbidities (8.3% vs. 50.0%, P=0.023). Optimal 
debulking rates between the two groups were similar (91.7% vs. 
75.0%, P=0.254). 
  The median duration of follow-up for the entire cohort was 
38.2 months (range, 1.7 to 87.5). The progression free survival 
(PFS) and overall survival (OS) are illustrated in Fig. 1. The me-
dian PFS was 22 months (95% confidence interval [CI], 16.6-40.2) 
for the elderly patients, and 31.5 months (95% CI, 22.9-53.9) for 
the young patients (P=0.190, by log-rank test, Fig. 1A). Backward 
Table 5. Comparison of characteristics, operative outcome, and complications between elderly patients who received multiple (more than one) EUAS procedures and elderly 
patients who received single or no EUAS procedures
Single or no UAS procedure 
(n=24)
Multiple UAS procedures 
(n=8)
Total 
(n=32)
P value
Age, range median (yr)    68 (65-79) 66.5 (65-77)      67 (65-79) 0.390
Rate of co-morbidity 0.458 0.750 0.531 0.382
Charlson index 0.167 0.250 0.188 0.672
Stage of disease
   III 
   IV 
    19 (79.2%)
      5 (20.8%)
      5 (62.5%)
      3 (37.5%)
      24 (75.0%)
        8 (25.0%)
0.641
†
Preoperative CA125     1,292.5 (9.8-20,900)      1,149 (133-7,580)          1,212 (9.8-20,900) 0.610*
Estimated blood loss (mL)        800 (300-2,000)         1,600 (1,000-2,300)        1,000 (300-2,300) 0.002*
Operating time (min) 422.5 (45-667)   609.5 (410-649)      457 (45-667) 0.009*
Hospital stay (days)  18 (9-62)    23 (15-51) 18.5 (9-62) 0.163
Optimal resection     22 (91.7%)       6 (75.0%)       28 (87.5%) 0.254
Intraoperative transfusion      13 (54.2%)         8 (100.0%)       21 (65.6%) 0.030
†
Intraoperative surgical injuries       3 (12.5%)       1 (12.5%)         4 (12.5%) 1.000
†
30 days postoperative morbidities        3 (12.5%)       2 (25.0%)         5 (15.6%) 0.578
†
Iatrogenic surgical morbidities      2 (8.3%)       4 (50.0%)         6 (18.8%) 0.023
† 
*Mann-Whitney test was used; 
†Fisher exact test was used. EUAS, extensive upper abdominal surgery.
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Fig. 1. Kaplan-Meier survival analysis of the young and the elderly patients with advanced ovarian cancer. (A) Progression free survival distribution by age (P=0.190, by log-
rank test). (B) Overall survival distribution by age (P=0.016, by log-rank test).
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stepwise multivariate Cox hazard analysis revealed that the pres-
ence of gross residual tumor was the only independent risk fac-
tor predicting PFS (P=0.034, 95% CI, 1.05-3.22). In the elderly, 
the median OS was 57.8months (95% CI, 20.0–63.4), whereas 
the median OS was not reached in the young patients. The log 
rank test showed that elderly patients had a shorter OS than the 
younger group (P=0.016, Fig. 1B). Again, however, backward 
stepwise multivariate Cox proportional hazard analysis revealed 
that the presence of residual tumor was the independent prog-
nostic factor (P=0.011, 95% CI, 1.32-8.72). In patients with age 
>75 yr, overall survival was less than 10 months in 4 of 5 patients 
in spite of optimal cytoreduction. The remaining one patient 
survived 57 months.
 
DISCUSSION
The present study showed that EUAS can be performed with 
careful perioperative management in elderly patients with ad-
vanced ovarian cancer. In the elderly patients, we achieved an 
optimal debulking rate of 87.5% with EUAS. We also observed 
that intraoperative complication rates, 30 day postoperative 
morbidity and other operative outcomes were similar between 
the young and elderly patients. For example, the frequency of 
infectious complications was not different between the young 
and elderly patients who had a splenectomy (12.5% vs. 8.3%, 
P=1.000). Therefore, we suggest that EUAS may be safe and fea-
sible in fit, elderly patients.
  In the recent study demonstrating that EUAS can help increase 
the optimal cytoreduction rate, Chi et al. (17) included patients 
up to 88 yr of age and reported a 76% of optimal cytoreduction 
rate. Recently, Wright et al. (10) reported the surgical outcome 
of 46 elderly women, including 33 cases with advanced disease. 
In the study, they reported that 2% of elderly patients had a sple-
nectomy and the optimal cytoreduction rate for the elderly 
group (including 22% of early stage patients) was 81%. Recently, 
Sharma et al. (12) reported an 89.6% optimal debulking rate in-
volving 77 elderly patients, including 26% early stage patients. 
They defined ‘supraradical’ surgical procedures as splenecto-
my, and/or diaphragm resection, and/or liver resection, and/or 
combined small and large bowel resection, and/or exenteration. 
In the study, 15 elderly patients (19.4%) underwent ‘supraradi-
cal’ procedures. In our study, we applied EUAS to 16 of 32 el-
derly patients (50.0%). Our optimal debulking rate (87.5%) was 
similar to the previous study. However, it should be noted we 
included only patients with advanced disease, while the previ-
ous studies included 22-26% patients of early stage ovarian can-
cers. As Bristow et al. (24) demonstrated in their meta-analysis, 
our data also showed that a high optimal debulking rate can be 
translated into an improved OS (median survival 57.8 months) 
in elderly patients with advanced ovarian cancer.
  In terms of surgical complication, our data suggest that there 
is no difference between young patients and fit, elderly patients 
in general. This corresponds with the results of previous studies 
(10, 12, 13). However, our data raised a concern that the incor-
poration of upper abdominal procedures may increase the fre-
quency of specific complications and may cause more physical 
burden to the elderly patients who underwent EUAS procedures. 
First, we observed that pleural effusions and pneumothorax 
were more likely to develop in elderly patients who underwent 
EUAS procedures. Post-operative pleural effusions are relatively 
common complications in patients who undergo diaphragm 
resection and/or stripping (25-27). Previous reports emphasize 
that most of the cases can be managed without respiratory com-
promise or further complications. Also, in the report by Eisen-
hauer et al. (26), the age of the patients who had effusions after 
diaphragm peritonectomy was not different from that of patients 
that did not undergo diaphragm peritonectomy. Therefore, at 
the present time, it is not clear that diaphragmatic surgery is the 
cause of more frequent post-operative pleural effusion in the 
elderly. However, given that elderly patients are more vulnera-
ble to respiratory complications, such as pneumonia or respira-
tory distress, we recommend that intensive care should be given 
to the elderly patients, especially when they received diaphragm 
surgery and/or a splenectomy. Second, we found that elderly 
patients who received multiple EUAS had increased blood loss, 
longer operating time, and more frequent intraoperative trans-
fusions. Since all of these factors can deteriorate the postopera-
tive outcomes of elderly patients, unnecessary upper abdomi-
nal procedures should be minimized.
  There were several limitations of our study. In addition to the 
small sample size of the study, one of the major limits of our 
study was the nature of the retrospective study design, which is 
vulnerable to selection bias. Therefore, the elderly patients in 
our study may not represent elderly patients from the general 
population. Second, our data did not provide an answer for a 
concern that EUAS may impair quality of life, especially in the 
elderly patient. Given that the profiles of complications and mor-
bidities were similar between the young and elderly groups, it is 
very tempting to assume that the impairment of quality of life 
in elderly patients may not be more severe than young patients. 
However, a further prospective trial is necessary to elucidate this 
question. Third, physical age and mental status irrespective of 
chronological age used in this study must be considered in the 
future study. Finally, although we have recommended surgery 
to every elderly patient with a favorable performance score, no 
severe multiple co-morbidities and adequate activities of daily 
living, our study did not provide the exact selection criteria for 
recruiting the ‘fit’ elderly into surgery. Therefore, how to select 
‘fit’ patients for extensive surgery, including upper abdominal 
procedures, is still not determined. Recently, Alphs et al. (11) 
suggested that age over 80 yr, poor nutritional state, and an un-
favorable co-morbidity index can predict an unfavorable out-Lim MC, et al.  •  Extensive Surgery In Elderly with Ovarian Cancer
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come in elderly patients. Janda et al. (28) also suggests that the 
risk factor profile, including age, stage, treatment facility, and 
co-morbidity, can help determine whether we should give stan-
dard surgery to elderly patients. Therefore, to improve the out-
come of elderly ovarian cancer patients, it is necessary to launch 
a prospective randomize study to validate the usefulness of these 
predictive factors and to establish an adequate patient selection 
system.
  Since recent evidences repeatedly stress that standard care 
should be given to elderly patients with advanced ovarian can-
cer, now the concern has shifted to how aggressive the surgery 
should be. Our results suggest that not only standard operative 
care but EUAS is feasible in fit elderly patients with advanced 
stage ovarian cancer. However, a gynecologist always should 
make every effort to minimize unnecessary radical procedures, 
especially in elderly patients. Also, more careful peri-operative 
care should be offered to elderly patients when they receive two 
or more EUAS procedures.
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